Cardiac Gene Therapy With Phosphodiesterase 2A Limits Remodeling and Arrhythmias in Mouse Models of Heart Failure
Background PDE2 (phosphodiesterase 2) is upregulated in human heart failure. Cardiac PDE2‐transgenic mice are protected against contractile dysfunction and arrhythmias in heart failure but whether an acute elevation of PDE2 could be of therapeutic value remains elusive. This hypothesis was tested us...
Saved in:
Main Authors: | Rima Kamel, Aurélia Bourcier, Jean Piero Margaria, Valentin Jin, Audrey Varin, Agnès Hivonnait, Françoise Mercier‐Nomé, Delphine Mika, Alessandra Ghigo, Flavien Charpentier, Vincent Algalarrondo, Emilio Hirsch, Rodolphe Fischmeister, Grégoire Vandecasteele, Jérôme Leroy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-02-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.124.037343 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of phosphodiesterase 4B in IL-8/LTB4-induced human neutrophil chemotaxis evaluated with a phosphodiesterase 4B inhibitor
by: Suzuki Osamu, et al.
Published: (2015-06-01) -
Phosphodiesterase 4 inhibition as a novel treatment for stroke
by: Jiahong Zhong, et al.
Published: (2025-01-01) -
Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology
by: Elena Carmona-Rocha, et al.
Published: (2025-01-01) -
Mechanisms of L-citrulline on phosphodiesterase 5 in erectile dysfunction intervention
by: Abdulhakeem Olarewaju Sulyman, et al.
Published: (2025-03-01) -
Phosphodiesterase Type 5 Inhibitors in Male Reproduction: Molecular Mechanisms and Clinical Implications for Fertility Management
by: Aris Kaltsas, et al.
Published: (2025-01-01)